A phase 2 evaluation of 1-(2-chloroethyl)-3-(4- methylcyclohexyl)-1-nitrosourea (NSC 95441) in patients with advanced breast cancer
- PMID: 4809462
A phase 2 evaluation of 1-(2-chloroethyl)-3-(4- methylcyclohexyl)-1-nitrosourea (NSC 95441) in patients with advanced breast cancer
Similar articles
-
Evaluation of 1-(2-chloroethyl-3-4-methylcyclohexyl)-1-nitrosourea (methyl-CCNU, NSC 95441) versus combined imidazole carboxamide (NSC 45338) and vincristine (NSC 67574) in palliation of disseminated malignant melanoma.Cancer. 1974 Mar;33(3):615-8. doi: 10.1002/1097-0142(197403)33:3<615::aid-cncr2820330304>3.0.co;2-f. Cancer. 1974. PMID: 4131357 No abstract available.
-
Difficulties designing clinical trials as exemplified by a phase 2 drug evaluation of 5(3,3-bis(2-chloroethyl)-1-triazenol)-imidazole-4-carboxamide and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in patients with disseminated breast cancer.Cancer Res. 1973 Jul;33(7):1707-10. Cancer Res. 1973. PMID: 4578655 Clinical Trial. No abstract available.
-
Sequential 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037) and 5-fluorouracil (NSC 19893) therapy of gastrointestinal cancer.Cancer Res. 1972 Jun;32(6):1280-2. Cancer Res. 1972. PMID: 5030827 No abstract available.
-
An overview of the status of the nitrosoureas in other tumors.Cancer Chemother Rep 3. 1973 May;4(3):35-46. Cancer Chemother Rep 3. 1973. PMID: 4584034 Review. No abstract available.
-
[Cytostatic therapy: neurologic and psychiatric syndromes].Med Klin. 1980 Jun 20;75(13):478-84. Med Klin. 1980. PMID: 6997713 Review. German. No abstract available.
Cited by
-
Single agent versus combination chemotherapy for metastatic breast cancer.Cochrane Database Syst Rev. 2009 Apr 15;2009(2):CD003372. doi: 10.1002/14651858.CD003372.pub3. Cochrane Database Syst Rev. 2009. PMID: 19370586 Free PMC article.